Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Heather Symons, MD, MHS
SKCCC Johns Hopkins Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital of Colorado
Aurora, Colorado, United States
- Nemours Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- All Children'S Hospital Johns Hopkins Medicine
St. Petersburg, Florida, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- Levine Cancer Center
Charlotte, North Carolina, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Jul 2015
- Primary completion
- 15 Jun 2018
- Completion
- 1 Oct 2020
- Last update posted
- 26 Nov 2021
- Registered enrollment
- 35
- Registry id
- NCT02120157
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.